FCS-11784-70241
3 vaccinations
3 coded responses
18 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 452 / OH
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
7ED-33512-18242
Child or adolescent in my care · Female · 2022-05-04
Timeline
-
2021-08-06
Dose 1 — Pfizer-BioNTech
-
2021-08-13
Registered in v-safe
- 2021-08-13
- 2021-08-20
-
2021-08-27
Dose 2 — Pfizer-BioNTech
- 2021-08-27
-
2021-08-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-30
Survey response — days 1–6 daily, dose 2MedDRA: Dry eye — Feeling: Good · HeadacheFree text: Dry eyesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-31
Survey response — days 1–6 daily, dose 2MedDRA: Dry eye — Feeling: Good · HeadacheFree text: Dry eyeMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-10
- 2021-09-17
-
2021-09-24
Survey response — day 28, dose 2MedDRA: Caesarean section, Haematoma, Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Postpartum pre-eclampsia and a hematoma near my c-section One of my twins has developed NECMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Report sent to call center — day 28, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-09-27
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-01
- 2021-10-08
- 2021-11-26
-
2022-02-27
Dose 3 — Pfizer-BioNTech
- 2022-02-27
- 2023-02-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Pfizer-BioNTech | No |
| 2 | 2021-08-27 | Pfizer-BioNTech | No |
| 3 | 2022-02-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Dry eyes
Systemic reaction (other): Dry eye
Release 9 — day 28, dose 2
Symptoms: Postpartum pre-eclampsia and a hematoma near my c-section One of my twins has developed NEC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Caesarean section | · | · | ✓ |
| SD | Haematoma | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SRO | Dry eye | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release